Pharmaceutical Executive-03-01-2002
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership
2
Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somnivera
3
Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics
4
The Most Surprising Development in GLP-1s
5